Combinations of the Phosphatidylinositol 3-Kinase-Delta (PI3K delta) Inhibitor Gs-1101 (CAL-101) with Rituximab and/or Bendamustine Are Tolerable and Highly Active in Previously Treated, Indolent Non-Hodgkin Lymphoma: Results From a Phase I Study 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Fowler, N. H., de Vos, S., Schreeder, M. T., Leonard, J. P., Flinn, I. W., Coutre, S., Wagner-Johnston, N. D., Sharman, J., Boccia, R. V., Barrientos, J. C., Boyd, T. E., Holes, L. M., Lannutti, B. J., Johnson, D., Jahn, T. M., Miller, L. L., Godfrey, W. R. AMER SOC HEMATOLOGY. 2012

View details for Web of Science ID 000314049600297